Home · Compare

Mayukh Sukhatme vs Sarah Gheuens M.D. Ph.D.

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $251.6M (93016%) more than Sarah Gheuens M.D. Ph.D. in their most recent fiscal years on record.

Mayukh SukhatmeSarah Gheuens M.D. Ph.D.

CompanyRoivant SciencesAgios Pharmaceuticals

TitlePresident and Chief Investment OfficerExecutive Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2025

Total Pay$251.9M$270,478

Base Salary$550,000—

Stock Awards$170.2M—

Bonus$81.1M—

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Mayukh Sukhatme's full profile · Sarah Gheuens M.D. Ph.D.'s full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy